Clear Harbor Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Clear Harbor Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$404K	–	479
2025 Q3	$404K	Hold	20,000	–	–	0.03%	316
2025 Q2	$335K	Buy	+20,000	New	+$323K	0.03%	323
2024 Q1	–	Sell	-16,000	Closed	-$167K	–	403
2023 Q4	$167K	Hold	16,000	–	–	0.02%	337
2023 Q3	$163K	Buy	16,000 +10,000	+167%	+$93.1K	0.02%	315
2023 Q2	$45.2K	Hold	6,000	–	–	﹤0.01%	352
2023 Q1	$53.1K	Buy	+6,000	New	+$59.3K	0.01%	378

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clear Harbor Asset Management's TEVA Position: Q1 2026 in Review

Clear Harbor Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 3.5% in Q1 2026, selling an estimated $104K and leaving 88,122 shares worth $2.65M. The position accounts for 0.18% of the portfolio, ranked #106.

Clear Harbor Asset Management first reported a position in TEVA in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.85M in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Clear Harbor Asset Management held 88,122 shares of Teva Pharmaceuticals worth $2.65M as of Q1 2026.
Clear Harbor Asset Management sold 3,225 Teva Pharmaceuticals shares in Q1 2026, an estimated $104K.
Teva Pharmaceuticals made up 0.18% of Clear Harbor Asset Management's portfolio in Q1 2026, its #106 holding.
Clear Harbor Asset Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
Clear Harbor Asset Management's Teva Pharmaceuticals position peaked at $2.85M in Q4 2025.
651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.